Lina Han
No. 36, Sanhao Street
Shenyang, 110004, China
Shenyang, 110004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Response to Letter Regarding Article, "Efficacy and Safety of Omalizumab Combined With Allergen Immunotherapy in Children With Moderate to Severe Allergic Asthma".
Journal: International forum of allergy & rhinology
Published: June 21, 2025
Protective effect of micheliolide against inflammation and oxidative stress in asthma through the MAPK/NF-κB signalling pathway.
Journal: The World Allergy Organization journal
Published: January 15, 2025
Parents' knowledge, attitudes and practices towards the prevention and treatment of dust mite allergy: a cross-sectional study in Shenyang (China).
Journal: BMJ open
Published: January 14, 2025
BHLHE40 contributes to allergic asthma progression in mice through NRTN downregulation in macrophages.
Journal: Communications biology
Published: August 25, 2024
Efficacy and safety of omalizumab combined with allergen immunotherapy in children with moderate to severe allergic asthma.
Journal: International forum of allergy & rhinology
Published: May 15, 2024
Macrolide resistance of Mycoplasma pneumoniae in several regions of China from 2013 to 2019.
Journal: Epidemiology and infection
Published: April 18, 2024
Safety of subcutaneous immunotherapy with Novo-Helisen-Depot in the children: a retrospective analysis from a single center in Northern China.
Journal: Frontiers in pediatrics
Published: January 14, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026